Published in J Virol on September 01, 1984
Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74
Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol (1998) 2.61
The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J (1996) 2.27
Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med (1989) 2.15
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A (1988) 2.12
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1989) 2.01
Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol (2001) 1.64
In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol (1989) 1.60
Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.54
Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers. J Virol (2003) 1.45
Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus. J Virol (1986) 1.31
Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J Virol (1999) 1.24
Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol (2001) 1.11
Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol (2001) 1.10
Detection of Epstein-Barr virus genomes in normal human lacrimal glands. J Clin Microbiol (1990) 1.07
Gene expression during osteogenic differentiation in mandibular condyles in vitro. J Cell Biol (1990) 1.06
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines. J Virol (1994) 1.05
Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis (1988) 1.03
Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci U S A (1991) 1.03
The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol (1991) 1.02
Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol (1989) 1.01
Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol (1991) 0.95
Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome. Am J Pathol (1993) 0.95
Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol (1991) 0.93
Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. J Virol (1995) 0.89
c-fos expression precedes osteogenic differentiation of cartilage cells in vitro. J Cell Biol (1990) 0.85
Epstein-Barr virus in a CD8-positive T-cell lymphoma. Am J Pathol (1990) 0.84
Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells. J Virol (1989) 0.82
Sporadic EBV-associated lymphoepithelial salivary gland carcinoma with EBV-positive low-grade myoepithelial component. Virchows Arch (2006) 0.82
Subcellular distribution and life cycle of Epstein-Barr virus in keratinocytes of oral hairy leukoplakia. Am J Pathol (1991) 0.79
Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome. J Clin Pathol (1999) 0.78
The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells. Proc Natl Acad Sci U S A (2006) 0.78
Detection of pseudorabies virus DNA in the inner ear of intranasally infected BALB/c mice with nucleic acid hybridization in situ. J Virol (1986) 0.75
The expression of Ia-antigen on nasopharyngeal carcinomas xenografted into nude mice. Arch Otorhinolaryngol (1985) 0.75
Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Detection of human salivary gland virus in the mouth and urine of children. Am J Hyg (1958) 1.77
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
Localization of viral antigen in chickens infected with Marek's disease herpesvirus. J Natl Cancer Inst (1969) 1.65
Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (1975) 1.35
Site of Epstein-Barr virus replication in the oropharynx. Lancet (1979) 1.34
Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis (1973) 1.20
The spontaneous and induced synthesis of Epstein-Barr virus antigens in Raji cells immobilized on surface coated with anti-lymphocyte globulin. J Gen Virol (1981) 0.98
The isolation of mumps at autopsy. Am J Pathol (1949) 0.94
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci (1988) 5.00
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol (1987) 4.12
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79. Int J Epidemiol (2007) 3.13
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies. Med Phys (1999) 2.64
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements. Med Phys (1999) 2.29
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol (2013) 2.25
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology (1993) 2.20
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Dose reduction in computed tomography by attenuation-based on-line modulation of tube current: evaluation of six anatomical regions. Eur Radiol (2000) 1.93
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol (1992) 1.86
Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses (1998) 1.83
E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J Virol (1998) 1.83
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol (2001) 1.81
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology (2000) 1.77
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes. Eur J Biochem (1977) 1.63
PCR-based detection of mycobacteria in sputum samples using a simple and reliable DNA extraction protocol. Biotechniques (1994) 1.63
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60
Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol (1998) 1.60
Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci U S A (1980) 1.59
Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol (1989) 1.58
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol (1995) 1.57
Specific and sensitive two-step polymerase chain reaction assay for the detection of Salmonella species. Eur J Clin Microbiol Infect Dis (1996) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Purification and properties of Herpesvirus saimiri DNA. Virology (1974) 1.55
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci U S A (1997) 1.55
Dose reduction in CT by on-line tube current control: principles and validation on phantoms and cadavers. Eur Radiol (1999) 1.53
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther (2000) 1.52
Polymer-supported bilayer on a solid substrate. Biophys J (1992) 1.50
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res (1997) 1.49
[Assessment of late pregnancy terminations, 2004-2007]. Ned Tijdschr Geneeskd (2008) 1.45
Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J Virol (1997) 1.44
Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med (1996) 1.43
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect (1979) 1.43
[Pyelonephritis during pregnancy: a threat to mother and child]. Ned Tijdschr Geneeskd (2007) 1.42
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor. Eur J Biochem (1977) 1.41
[Cartilage-specific autoimmunity in otosclerosis]. HNO (1993) 1.40
Urgent dietary intervention required in urbanising communities to prevent allergy epidemic. S Afr Med J (1992) 1.39
[The Vancouver rules and the scientific ethical committee system]. Ugeskr Laeger (2001) 1.39
[Late postpartum eclampsia]. Ned Tijdschr Geneeskd (2007) 1.38
Allergology in South Africa. S Afr Med J (1994) 1.38
Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (1975) 1.35
Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem (1999) 1.33
Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches. Eur J Immunol (1996) 1.33
Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol (1999) 1.31
Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus. J Virol (1986) 1.31
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res (1996) 1.29
"Hit-and-run" transformation by adenovirus oncogenes. J Virol (2001) 1.29
Epstein--Barr virus-induced cell fusion. Nature (1980) 1.29
First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand (1995) 1.25
Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study. Thromb Haemost (1999) 1.23
Dose reduction in subsecond multislice spiral CT examination of children by online tube current modulation. Eur Radiol (2004) 1.23
Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. Proc Natl Acad Sci U S A (1986) 1.22
Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes. Proc Natl Acad Sci U S A (1977) 1.22
Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus. J Biol Chem (1995) 1.20
Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res (2001) 1.20
Thyrotropin-releasing hormone precursor: characterization in rat brain. Science (1986) 1.20
Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J Gen Virol (1994) 1.19
The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle. J Gen Virol (1981) 1.17
Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol (1990) 1.16
Sequence variability among different parvovirus B19 isolates. J Gen Virol (1996) 1.16
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res (2001) 1.15
Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res Hum Retroviruses (2000) 1.15
EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. Cold Spring Harb Symp Quant Biol (1975) 1.14
Specific detection of monkeypox virus by polymerase chain reaction. J Virol Methods (1998) 1.12
Perforation of continent urinary reservoirs. Scandinavian experience. Scand J Urol Nephrol (1997) 1.11
Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J Biol Chem (1999) 1.11
Is psychosocial stress in first ongoing pregnancies associated with pre-eclampsia and gestational hypertension? BJOG (2008) 1.10
Immunoglobulin M anti-hepatitis A virus determination reorienting gradient centrifugation for diagnosis of Acute Hepatitis A. J Clin Microbiol (1979) 1.10
Conformational response of the glycocalyx to ionic strength and interaction with modified glass surfaces: study of live red cells by interferometry. J Cell Sci (1983) 1.10
The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP. J Biol Chem (1982) 1.09
Molecular alterations in bladder cancer. Urol Res (1998) 1.09
Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur J Immunol (1994) 1.08
Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol (2000) 1.08
Studies on the effect of distamycin A on the DNA dependent RNA polymerase system. Biochem Biophys Res Commun (1971) 1.07
Red blood cells experience electrostatic repulsion but make molecular adhesions with glass. Biophys J (1985) 1.07
Monosomy X found at first trimester CVS: a diagnostic and counselling dilemma. Clin Genet (1990) 1.07
Mapping of Epstein-Barr virus proteins on the genome by translation of hybrid-selected RNA from induced P3HR1 cells and induced Raji cells. Virology (1985) 1.06
High level expression of hepatitis B virus surface antigen in stably transfected Drosophila Schneider-2 cells. J Virol Methods (1999) 1.06
Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein-derived peptides. J Gen Virol (1994) 1.06
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev (1997) 1.05
A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study. Antibiot Chemother (1971) (1996) 1.05
Expression of the Epstein-Barr virus 138-kDa early protein in Escherichia coli for the use as antigen in diagnostic tests. Gene (1986) 1.05
High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res (2001) 1.05